Barbara Ruskin - 24 Mar 2023 Form 3 Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role: Director
Signature: /s/ Anthony Mack, attorney-in-fact
Issuer symbol: VRPX
Transactions as of: 24 Mar 2023
Net transactions value: $0
Form type: 3
Filing time: 28 Mar 2023, 20:00:17 UTC
Next filing: 31 Jan 2024
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney